Form 8-K - Current report:
SEC Accession No. 0001558370-25-011149
Filing Date
2025-08-12
Accepted
2025-08-12 08:05:18
Documents
52
Period of Report
2025-08-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K apre-20250812x8k.htm   iXBRL 8-K 41494
2 EX-99.1 apre-20250812xex99d1.htm EX-99.1 148038
3 EX-99.2 apre-20250812xex99d2.htm EX-99.2 59453
4 GRAPHIC apre-20250812xex99d1002.jpg GRAPHIC 8841
5 GRAPHIC apre-20250812xex99d2g001.jpg GRAPHIC 120736
6 GRAPHIC apre-20250812xex99d2g002.jpg GRAPHIC 147583
7 GRAPHIC apre-20250812xex99d2g003.jpg GRAPHIC 258863
8 GRAPHIC apre-20250812xex99d2g004.jpg GRAPHIC 115595
9 GRAPHIC apre-20250812xex99d2g005.jpg GRAPHIC 133754
10 GRAPHIC apre-20250812xex99d2g006.jpg GRAPHIC 168446
11 GRAPHIC apre-20250812xex99d2g007.jpg GRAPHIC 139491
12 GRAPHIC apre-20250812xex99d2g008.jpg GRAPHIC 89410
13 GRAPHIC apre-20250812xex99d2g009.jpg GRAPHIC 189347
14 GRAPHIC apre-20250812xex99d2g010.jpg GRAPHIC 168112
15 GRAPHIC apre-20250812xex99d2g011.jpg GRAPHIC 139033
16 GRAPHIC apre-20250812xex99d2g012.jpg GRAPHIC 128378
17 GRAPHIC apre-20250812xex99d2g013.jpg GRAPHIC 83628
18 GRAPHIC apre-20250812xex99d2g014.jpg GRAPHIC 74012
19 GRAPHIC apre-20250812xex99d2g015.jpg GRAPHIC 146985
20 GRAPHIC apre-20250812xex99d2g016.jpg GRAPHIC 213737
21 GRAPHIC apre-20250812xex99d2g017.jpg GRAPHIC 156157
22 GRAPHIC apre-20250812xex99d2g018.jpg GRAPHIC 131575
23 GRAPHIC apre-20250812xex99d2g019.jpg GRAPHIC 134233
24 GRAPHIC apre-20250812xex99d2g020.jpg GRAPHIC 205101
25 GRAPHIC apre-20250812xex99d2g021.jpg GRAPHIC 172399
26 GRAPHIC apre-20250812xex99d2g022.jpg GRAPHIC 139017
27 GRAPHIC apre-20250812xex99d2g023.jpg GRAPHIC 88261
28 GRAPHIC apre-20250812xex99d2g024.jpg GRAPHIC 163073
29 GRAPHIC apre-20250812xex99d2g025.jpg GRAPHIC 126522
30 GRAPHIC apre-20250812xex99d2g026.jpg GRAPHIC 193490
31 GRAPHIC apre-20250812xex99d2g027.jpg GRAPHIC 115587
32 GRAPHIC apre-20250812xex99d2g028.jpg GRAPHIC 80847
33 GRAPHIC apre-20250812xex99d2g029.jpg GRAPHIC 130712
34 GRAPHIC apre-20250812xex99d2g030.jpg GRAPHIC 192651
35 GRAPHIC apre-20250812xex99d2g031.jpg GRAPHIC 123912
36 GRAPHIC apre-20250812xex99d2g032.jpg GRAPHIC 141363
37 GRAPHIC apre-20250812xex99d2g033.jpg GRAPHIC 98833
38 GRAPHIC apre-20250812xex99d2g034.jpg GRAPHIC 162792
39 GRAPHIC apre-20250812xex99d2g035.jpg GRAPHIC 212758
40 GRAPHIC apre-20250812xex99d2g036.jpg GRAPHIC 149715
  Complete submission text file 0001558370-25-011149.txt   7594271

Data Files

Seq Description Document Type Size
41 EX-101.SCH apre-20250812.xsd EX-101.SCH 4089
42 EX-101.DEF apre-20250812_def.xml EX-101.DEF 2844
43 EX-101.LAB apre-20250812_lab.xml EX-101.LAB 16593
44 EX-101.PRE apre-20250812_pre.xml EX-101.PRE 10903
54 EXTRACTED XBRL INSTANCE DOCUMENT apre-20250812x8k_htm.xml XML 4677
Mailing Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902
Business Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902 215-948-4119
Aprea Therapeutics, Inc. (Filer) CIK: 0001781983 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39069 | Film No.: 251204125
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)